This grant is intended for researchers to study the mechanisms of antigen processing and presentation of novel peptidic and non-peptidic ligands. The research aims to understand how these unique antigenic ligands contribute to immune responses against infectious diseases, vaccine development, immune pathogenesis, and immune-mediated diseases. The outcomes of the research may lead to the development of tools and reagents for immune-based therapeutics and vaccines. The closing date for submissions is January 07, 2022, 12:00:00 AM EST.
Opportunity ID: 310315
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-19-066 |
| Funding Opportunity Title: | Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 13, 2018 |
| Last Updated Date: | Nov 13, 2018 |
| Original Closing Date for Applications: | Jan 07, 2022 |
| Current Closing Date for Applications: | Jan 07, 2022 |
| Archive Date: | Feb 12, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education County governments Native American tribal governments (Federally recognized) Special district governments Public housing authorities/Indian housing authorities City or township governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites applications to determine antigen processing and presentation mechanisms used in the generation of novel peptidic and non-peptidic ligands and to determine the contribution of these unique antigenic ligands to protective immune responses against infectious disease pathogens and/or vaccines; pathogen-associated immune pathogenesis; and/or limit progression or induction of immune-mediated diseases. These studies may facilitate the development of novel tools and reagents to advance design of immune-based therapeutics and vaccines. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-19-066.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00246239 | Jan 16, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259793 | Jan 16, 2019 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270220 | Nov 16, 2021 | Jan 07, 2022 | View |
Package 1
Mandatory forms
310315 RR_SF424_2_0-2.0.pdf
310315 PHS398_CoverPageSupplement_4_0-4.0.pdf
310315 RR_OtherProjectInfo_1_4-1.4.pdf
310315 PerformanceSite_2_0-2.0.pdf
310315 RR_KeyPersonExpanded_2_0-2.0.pdf
310315 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
310315 RR_Budget_1_4-1.4.pdf
310315 RR_SubawardBudget30_1_4-1.4.pdf
310315 PHS398_ModularBudget_1_2-1.2.pdf
310315 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
310315 RR_SF424_2_0-2.0.pdf
310315 PHS398_CoverPageSupplement_5_0-5.0.pdf
310315 RR_OtherProjectInfo_1_4-1.4.pdf
310315 PerformanceSite_2_0-2.0.pdf
310315 RR_KeyPersonExpanded_2_0-2.0.pdf
310315 PHS398_ResearchPlan_4_0-4.0.pdf
310315 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
310315 RR_Budget_1_4-1.4.pdf
310315 RR_SubawardBudget30_1_4-1.4.pdf
310315 PHS398_ModularBudget_1_2-1.2.pdf
310315 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
310315 RR_SF424_5_0-5.0.pdf
310315 PHS398_CoverPageSupplement_5_0-5.0.pdf
310315 RR_OtherProjectInfo_1_4-1.4.pdf
310315 PerformanceSite_4_0-4.0.pdf
310315 RR_KeyPersonExpanded_4_0-4.0.pdf
310315 PHS398_ResearchPlan_4_0-4.0.pdf
310315 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
310315 RR_Budget_3_0-3.0.pdf
310315 RR_SubawardBudget30_3_0-3.0.pdf
310315 PHS398_ModularBudget_1_2-1.2.pdf
310315 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
